Zacks’ actions in the news
Buy Apple and Microsoft Stock As 2021 Approaches?
In today’s episode of Full Court Finance at Zacks, we explore the bullish outlook for the market for 2021. The episode then delves into Apple AAPL and Microsoft MSFT to see if investors should consider buying either of the tech titans as 2021 approaches.
Inventories fell early Monday morning as countries rushed to ban travel from the UK. Steps are being taken to prevent a new, highly infectious strain of the coronavirus from spreading to more of Europe. But the slowdown improved by midday.
The reason for the return likely stems from wider positivity as 2021 approaches. Last week, healthcare workers in the United States began receiving the Covid-19 vaccine from Pfizer, and the advisory group of the FDA has recommended that Moderna’s vaccine be cleared for wide use. And federal officials expect about 100 million Americans to get vaccinated by February or March.
Meanwhile, the second stimulus bill is ready for a final vote in Congress. This could prove essential as many of the hardest hit areas of the economy face a harsh winter, with another round of restrictions. Along with vaccine progress and another likely wave of coronavirus aid, the earnings picture and the interest rate environment are both helping to set a bullish picture for 2021.
Despite the positivity, it might not be the best idea to dive into actions that require tons of person-to-person contact right now. And although the beaten path and cyclicals have made a comeback recently, technology is poised to dominate the market and our lives.
With that in mind, we explore why investors might want to view Apple and Microsoft stocks as they remain below their highs.
The iPhone giant is poised to continue expanding its high-end consumer tech segment. Additionally, its service unit which helps it compete with Netflix NFLX, Spotify SPOT and others has racked up hundreds of millions of paying subscribers. And that’s just the beginning.
Microsoft stock jumped around 2% on Monday amid a more general slowdown. The surge came after Citigroup analysts provided one of Wall Street’s most bullish MSFT targets. The call focused on the company’s growing cloud business, poised to help it grow for years alongside Amazon AMZN and others.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech industry is expected to surpass $ 775 billion by 2024 as scientists develop treatments for thousands of diseases. They are also finding ways to modify the human genome to literally erase our vulnerability to these diseases.
Zacks just released Century of Biology: 7 Biotech Stocks To Buy Now To Help Investors Profit From 7 Stocks That Are Ready to Outperform. Our recent biotech recommendations have produced gains of + 50%, + 83% and + 164% in as little as 2 months. The actions in this report could perform even better.
See these 7 revolutionary actions now >>
Want the latest recommendations from Zacks Investment Research? Today you can download 7 best stocks for the next 30 days. Click to get this free report
Microsoft Corporation (MSFT): Free Stock Analysis Report
Amazon.com, Inc. (AMZN): Free Stock Analysis Report
Apple Inc. (AAPL): Free Stock Analysis Report
Netflix, Inc. (NFLX): Free Stock Analysis Report
Spotify Technology SA (SPOT): Free Stock Analysis Report
To read this article on Zacks.com, click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Comments are closed.